Stock CYAD CELYAD ONCOLOGY SA
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Celyad Oncology SA

Equities

CYAD

BE0974260896

Real-time Euronext Bruxelles
Other stock markets
 06:34:39 2024-04-16 am EDT 		5-day change 1st Jan Change
0.314 EUR -7.65% Intraday chart for Celyad Oncology SA -12.29% -19.49%
Apr. 04 Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Feb. 09 Celyad Oncology Seeks Termination of Reporting Obligations to US SEC MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HC Wainwright Downgrades Celyad Oncology Neutral From Buy, Shares Plunge 12% at Midday Trading
MT
Wells Fargo Adjusts Celyad Oncology's Price Target to $11 from $20, Keeps Overweight Rating
MT
Wall Street Set for Narrow Gains, US Unemployment Rate Falls in November
MT
CELYAD ONCOLOGY : HC Wainwright Adjusts Celyad Oncology's Price Target to $15 From $17, Maintains Buy Rating
MT
CELYAD ONCOLOGY : JonesTrading Downgrades Celyad Oncology to Hold from Buy
MT
CELYAD ONCOLOGY : HC Wainwright Adjusts Celyad Oncology's Price Target to $18 From $22, Keeps Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CYAD Stock
  4. News Celyad Oncology SA
  5. Analyst Reco.